BTSG Financials Brightspring Health Services, Inc.
4 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 24.8% per year over the past 3 years.
Operating margin has been roughly flat, at 2.3% in the latest year.
Financial health
Total debt ($2.5B) exceeds cash ($88M); net debt is $2.4B.
Total debt has grown slower than revenue (-13.7% vs 24.8% per year).
Operating income covered interest expense 1.9× in the latest year, up from 0.6× 3 years ago.
Total debt is 5.5× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$12.9B
$189M
11.8%
2.3%
$395M
$2.5B
$88M
2024
$10.1B
$21M
12.6%
1.1%
-$57M
$2.6B
$61M
2023
$7.7B
-$155M
14.8%
0.8%
$137M
$3.4B
$12M
2022
$6.6B
-$54M
16.3%
1.8%
-$75M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$3.6B
$149M
13.3%
3.4%
$101M
$2.5B
$889M
Dec '25
$3.6B
$77M
11.6%
3.0%
$194M
$2.5B
$88M
Sep '25
$3.3B
$56M
11.8%
2.6%
$92M
$2.5B
$140M
Jun '25
$3.1B
$28M
11.9%
1.5%
$25M
$2.5B
$70M
Mar '25
$2.9B
$30M
11.8%
1.8%
$84M
$2.5B
$52M
Dec '24
$2.7B
$16M
12.3%
2.0%
$75M
$2.6B
$61M
Sep '24
$2.6B
-$8M
12.4%
1.1%
$7M
$2.7B
$36M
Jun '24
$2.4B
$20M
12.8%
1.6%
-$39M
$2.6B
$25M
Mar '24
$2.3B
-$46M
12.8%
-0.7%
-$101M
$2.6B
$58M
Dec '23
$2.4B
-$7M
15.5%
2.9%
$146M
$3.4B
$12M
Sep '23
$2.3B
-$131M
15.9%
-2.3%
$16M
—
—
Jun '23
$2.2B
$4M
17.2%
3.7%
-$46M
—
—
Mar '23
$2.0B
-$21M
16.5%
2.5%
$22M
—
—
Valuation over time
How the market has priced BTSG against its own fundamentals since 2024-01 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 162.1× (Dec '24) to 71.5× (Jun '26).
The price-to-sales ratio has risen from 0.3× (Jan '24) to 1.0× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is BTSG growing its revenue and profit?
Over the past 3 years, Brightspring Health Services, Inc.'s revenue has grown 24.8% per year. These are computed facts, not advice.
How much debt does BTSG have?
As of FY2025, Brightspring Health Services, Inc. reported $2.5B of total debt against $88M of cash; operating income covered interest expense 1.9×.
What is BTSG's profit margin?
In FY2025, gross margin was 11.8%, operating margin 2.3%, and net margin 1.5%.
What is BTSG's P/E ratio?
As of Jun '26, Brightspring Health Services, Inc. traded at a price-to-earnings ratio of about 71.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.